logo

For the Inventor, By the Inventor

Sudbury, MA, United States of America

Edward R Lee

This inventor holds 30 USPTO granted patents and 5 published patent applications and 6 EPO patents, primarily in Cationic Amphiphiles. Top assignees: Genzyme Corporation, Placon Therapeutics, Inc., Tarveda Therapeutics, Inc.. Active years: 1997-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward R Lee. Retrieved from https://idiyas.com/inventor/edward-r-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 

% Patents Active = 70.0

 

Average Co-Inventor Count = 6.4

ph-index = 13

Forward Citations = 697(Granted Patents)


Location History:

  • Lincoln Heights, MA (US) (1999)
  • Quincy, MA (US) (1997 - 2000)
  • Natick, MA (US) (1999 - 2002)
  • Sudbury, MA (US) (2012 - 2019)

Company Filing History:

goldMedal25 out of 824 
 
Genzyme Corporation
 patents
silverMedal4 out of 11 
 
Placon Therapeutics, Inc.
 patents
bronzeMedal1 out of 8 
 
Tarveda Therapeutics, Inc.
 patents
4. 1 out of 925 
 
University of Iowa Research Foundation
 patents
where one patent can have more than one assignee

Years Active: 1997-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Cationic Amphiphiles
Gene Therapy
Platinum Compounds
Cancer Treatment
Nanoparticles
Intracellular Delivery
Glucosylceramide Synthase
Cell Transfections
Therapeutic Molecules
Amphiphile Compositions
Targeting Complexes
Small Molecule Transport
30 patents (USPTO):Explore Patents
1. 10472380 - Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof (2019-11-12),
2. 10111853 - Compounds, compositions, and methods for the treatment of cancers (2018-10-30),
3. 9771387 - Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof (2017-09-26),
4. 9745294 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2017-08-29),
5. 9744153 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2017-08-29),
6. 9556214 - Compounds, compositions, and methods for the treatment of cancers (2017-01-31),
7. 9480657 - Cabazitaxel-platinum nanoparticles and methods of using same (2016-11-01),
8. 9272996 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2016-03-01),
9. 8940776 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2015-01-27),
10. 8309593 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2012-11-13),
11. 8304447 - 2-acylaminopropoanol-type glucosylceramide synthase inhibitors (2012-11-06),
12. 6383814 - Cationic amphiphiles for intracellular delivery of therapeutic molecules (2002-05-07),
13. 6331524 - Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy (2001-12-18),
14. 6323191 - Small molecule chloride transport (2001-11-27),
15. 6071890 - Organ-specific targeting of cationic amphiphile/DNA complexes for gene (2000-06-06),

Title: Spotlight on Inventor Edward R Lee from Sudbury, MA

Introduction: Meet Edward R Lee, a prolific inventor from Sudbury, MA, with an impressive portfolio of 30 patents to his name. His innovative work has made significant contributions to the field of cancer treatment and beyond.

Latest Patents:

1. "Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof" - This patent introduces novel platinum compositions with a heterocycle ligand and nanoparticles for treating cancer.

2. "Compounds, compositions, and methods for the treatment of cancers" - The patent explores compounds and compositions, including a platinum (IV) complex with carboxylate or carbamate ligands, for cancer treatment.

Career Highlights: Edward R Lee has shared his expertise with notable companies such as Genzyme Corporation and Placon Therapeutics, Inc. His innovative mindset and dedication have left a lasting impact on the industry.

Collaborations: Throughout his career, Edward R Lee has collaborated with esteemed professionals like David J Harris and Craig S Siegel. Together, they have worked on cutting-edge projects that have pushed the boundaries of innovation.

Conclusion: Edward R Lee's groundbreaking work in the development of cancer treatment technologies showcases his commitment to improving healthcare outcomes. His collaborations with industry experts reflect his collaborative spirit and drive for excellence. Sudbury, MA is proud to be home to such a talented inventor.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…